Christmas Patrick J.
Transaction: 08/01/2026
SELL
Change
-4,699
Price
$9.69
Filing
08/04/2026
Type
SELL
REGENXBIO Inc.
RGNX • Biotechnology
$8.94
▼ -0.26 (-2.83%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$473.96M
Growth
3.1%
Cash Flow
1/5
Trend
Volatile
Evidence
Healthy liquidity · 2.38High debt level · 2.54Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:20 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$8.94
Change-2.83%
Shares Out53.02M
Market Cap$473.96M
Enterprise Value$437.40M
52W Range5.46 - 16.19
Beta0.90
P/E-2.41
P/S2.72
P/B6.60
P/FCF-1.45
EV/Sales2.51
Price$8.94
Change-2.83%
Shares Out53.02M
Market Cap$473.96M
Enterprise Value$437.40M
52W Range5.46 - 16.19
Beta0.90
P/E-2.41
P/S2.72
P/B6.60
P/FCF-1.45
EV/Sales2.51
EV/EBITDA-3.02
EV/FCF-1.34
Earnings Yield-41.44%
FCF Yield-69.01%
Dividend Yield0.00%
Gross Margin88.09%
Oper. Margin-94.58%
Profit Margin-113.75%
Debt/Eq2.54
Current Ratio2.38
Quick Ratio2.38
Revenue 5Y3.06%
Target$19.60
Target Upside119.24%
Target Median$18.00
Target Range12.00 - 29.00
Volume1.77M
Avg Volume2.20M
EPS Surprise-0.36
Investment DNA
How strong this company looks for long-term investors
35
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
58/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
55/100
Why this score▼
Healthy liquidity · 2.38High debt level · 2.54Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 20 analyst votes · 2026-09-05
80/100
Bullish
Bullish
13
Hold
6
Bearish
1
Price Target
2026-08-07
Low
$12.00
Mean
$19.14
Median
$18.00
High
$32.00
Insider Transactions
Recent executive and insider activity
PAKOLA STEVE
Transaction: 08/01/2026
SELL
Change
-7,468
Price
$9.69
Filing
08/04/2026
Type
SELL
PAKOLA STEVE
Transaction: 07/02/2026
SELL
Change
-2,161
Price
$7.86
Filing
07/06/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Christmas Patrick J. | SELL | -4,699 | $9.69 | 08/01/2026 | 08/04/2026 |
| PAKOLA STEVE | SELL | -7,468 | $9.69 | 08/01/2026 | 08/04/2026 |
| PAKOLA STEVE | SELL | -2,161 | $7.86 | 07/02/2026 | 07/06/2026 |
| PAKOLA STEVE | SELL | -2,161 | $13.64 | 07/02/2026 | 07/06/2026 |
| Simpson Curran | SELL | -6,818 | $13.09 | 07/01/2026 | 07/06/2026 |
| Simpson Curran | BUY | +1,453 | $10.18 | 06/30/2026 | 07/06/2026 |
| Simpson Curran | BUY | +951 | $7.00 | 12/31/2025 | 07/06/2026 |
| PAKOLA STEVE | SELL | -36,725 | $7.86 | 07/01/2026 | 07/01/2026 |
| PAKOLA STEVE | SELL | -36,725 | $12.86 | 07/01/2026 | 07/01/2026 |
| PAKOLA STEVE | SELL | -19,608 | $11.04 | 06/29/2026 | 07/01/2026 |
| Bennett Jean | BUY | +9,807 | Not reported | 05/29/2026 | 06/02/2026 |
| Bennett Jean | BUY | +46,600 | $7.01 | 05/29/2026 | 06/02/2026 |
| Fox Allan M. | BUY | +9,807 | Not reported | 05/29/2026 | 06/02/2026 |
| Fox Allan M. | BUY | +46,600 | $7.01 | 05/29/2026 | 06/02/2026 |
| Glucksmann Alexandra | BUY | +9,807 | Not reported | 05/29/2026 | 06/02/2026 |
| Glucksmann Alexandra | BUY | +46,600 | $7.01 | 05/29/2026 | 06/02/2026 |
| KARABELAS ARGERIS N | BUY | +9,807 | Not reported | 05/29/2026 | 06/02/2026 |
| KARABELAS ARGERIS N | BUY | +46,600 | $7.01 | 05/29/2026 | 06/02/2026 |
| MIGAUSKY GEORGE V | BUY | +9,807 | Not reported | 05/29/2026 | 06/02/2026 |
| MIGAUSKY GEORGE V | BUY | +46,600 | $7.01 | 05/29/2026 | 06/02/2026 |